New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials
Clarivate Plc, a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced the launch of VeriSIM Life Translational Index™ on Cortellis...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, a leading science and technology company, launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through Synthia™ retrosynthesis software application programing interface (API) integration.
It combines generative AI,...
Empowering researchers with superior imaging performance for cutting-edge live-cell and three-dimensional applications
Agilent Technologies Inc. announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader. These features improve image quality and results by reducing deleterious effects on live-cell samples and enhancing...
In collaboration with leading cancer centers, research results to be presented from four studies across a breadth of breast tumor types and genomic alterations demonstrating Caris' impact on precision medicine
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative...
Silence Therapeutics plc, an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced Curtis Rambaran, MD, previously Silence’s Vice President, Head of Clinical Science, has been promoted to Chief Medical Officer, and Marie Wikström Lindholm, PhD, previously Silence’s Senior...
Evaxion Biotech A/S, a clinical-stage TechBio company focused on developing AI-Immunology™-powered vaccines is pleased to present its novel precision vaccine concept at the 65th Annual Meeting of the American Society of Hematology (ASH), December 9-12, 2023, in San Diego, California.
Selected for Oral Presentation – Evaxion was selected for oral presentation...
Lantern Pharma Inc., an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, announced that the U.S. Food and Drug Administration (FDA) has granted LP-284 Orphan Drug Designation (ODD) for the treatment of...
Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, announced plans to launch a first-of-its-kind study aimed at developing of a seizure prediction algorithm for people with epilepsy, based on real-world data collected using the company's technology.
According to figures from the...
Global life sciences consulting firm ZoomRx is set to transform how life sciences brands monitor and evaluate TV ad campaigns with today’s launch of ZoomRx TV Tracking. ZoomRx TV Tracking combines two distinct assets – custom-built panels of verified patients and patent-pending mobile technology – to measure individual-level TV...
ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued to ENDRA a new patent, U.S. Patent No. 11828727 (the ‘727 patent) titled “Thermoacoustic Probe.”
The ‘727 patent relates to a thermoacoustic probe design with an optical...
